NutriClaim invited speaker 4th Fresenius International Conference Health Claims

  NutriClaim’s presentation will deal with the issue of to what extent ‘established’ scientific concepts are really fit for health claims substantiation. In addition to EFSA’s scientific guidance documents, guidance provided by opinions will be discussed. Examples will be taken from opinions on probiotics and immunity, walnuts and endothelium-dependent vasodilation, carotenoids and photoprotection and soy protein and cholesterol. Implications for […] >> read more

Will EFSA accept that Bifidobacterium BB-12 really improves immune function?

Recently, Rizzardini et al. (B. J. Nutr. 2011) showed that in a vaccination model in healthy subjects supplementation with either Bifidobacterium BB-12 or Lactobacillus casei 431 resulted in significantly greater mean fold increases in total and vaccine-specific antibody titers. However, the question remains whether the observed and statistically significant differences will also be perceived as physiologically relevant by EFSA in […] >> read more

Novel Foods – what to expect from EFSA?

NutriClaim was among the participants of the Novel Food Workshop who gathered in Brussels last week (23rd June) to discuss the practical application of Regulation 258/97. Also high-up the agenda was the issue of what a new Novel Food Regulation will bring in terms of speed of the evaluation (by EFSA) and transparency of the process. Indeed, as was emphasized […] >> read more